Shamburg News · 8-K filed Nov 16, 2026, 9:18 AM EST
MiniMed Group Gets FDA Clearance for MiniMed Fit Patch Pump; Updates FY2027 Adjusted EBITDA Margin Guidance
MMED · MiniMed Group, Inc.
- Other event
- Financing
- Other
- Materiality: high
MiniMed Group, Inc. announced on November 16, 2026 that the FDA cleared the MiniMed Fit patch pump and that U.S. launch is now anticipated in Spring 2027 rather than Summer 2027. MiniMed expects a one-time $162 million charge in the third quarter of fiscal 2027 tied to a previously disclosed minimum payment under its research and development agreement with affiliates of Blackstone Life Sciences Advisors, and it will not exclude this charge from adjusted EBITDA. It updated fiscal 2027 adjusted EBITDA margin guidance to approximately 11.3% from approximately 16%, stating the change reflects only this charge.
Source: SEC EDGAR, Form 8-K, Items 7.01, 9.01, accession 0001104659-26-127725.
Written from the filing by Shamburg Markets. Figures are as reported by the company.